DHC DIVERSIFIED HEALTHCARE TRUST
Real Estate Investment Trusts · Nasdaq · SEC CIK 1075415 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-3.8%
TTM net income YoY56.8%
TTM EPS YoY57.1%
Revenue 3-yr CAGR2.2%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin-10.3%
FCF margin-4.4%
EBITDA margin—
Returns
ROE-9.5%
ROA-3.4%
ROIC (approx.)—
Asset turnover0.33x
Leverage & solvency
Liabilities / assets63.5%
Debt / equity1.60x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.35x
Accruals ratio-4.6%
Payout ratio—
Capex / revenue8.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.54B | $1.50B | $1.41B | $1.28B | $1.38B |
| SG&A expense | $45.50M | $26.52M | $26.13M | $26.43M | $34.09M |
| Interest expense | $204.50M | $235.24M | $191.78M | $209.38M | $255.76M |
| Pretax income | -$320.90M | -$371.38M | -$272.67M | -$21.12M | $181.36M |
| Income tax | $1.74M | $467,000 | $445,000 | $710,000 | $1.43M |
| Net income | -$285.89M | -$370.25M | -$293.57M | -$15.77M | $174.51M |
| EPS (basic) | -1.19 | -1.55 | -1.23 | -0.07 | 0.73 |
| EPS (diluted) | -1.19 | -1.55 | -1.23 | -0.07 | 0.73 |
| Dividends declared per share | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Weighted avg. shares (diluted) | 240.29M | 239.53M | 238.84M | 238.31M | 237.97M |
| Balance sheet | |||||
| Cash & equivalents | $105.41M | $149.85M | $245.94M | $688.30M | $1.02B |
| Intangibles | $20.66M | $26.30M | $33.95M | $45.35M | $48.75M |
| Total assets | $4.36B | $5.14B | $5.45B | $6.00B | $6.62B |
| Long-term debt | $2.44B | $3.05B | — | — | — |
| Total debt | $2.44B | $3.05B | — | — | — |
| Total liabilities | $2.70B | $3.18B | $3.11B | $3.36B | $3.96B |
| Shareholders' equity | $1.67B | $1.96B | $2.34B | $2.64B | $2.66B |
| Net debt | $2.34B | $2.90B | — | — | — |
| Shares outstanding | 242.12M | 241.27M | 240.42M | 239.69M | 238.99M |
| Cash flow statement | |||||
| Operating cash flow | -$19.62M | $112.22M | $10.48M | -$40.35M | -$63.32M |
| Capital expenditure | $146.82M | $201.70M | $235.01M | $299.39M | $227.60M |
| Free cash flow | -$166.44M | -$89.48M | -$224.52M | -$339.74M | -$290.93M |
| Investing cash flow | $483.57M | -$187.02M | -$202.11M | $387.71M | $242.70M |
| Financing cash flow | -$492.01M | -$22.31M | -$249.71M | -$676.00M | $746.72M |
| Depreciation & amortization | $261.92M | $284.96M | $284.08M | $239.28M | $271.13M |
| Stock-based compensation | $3.41M | $2.75M | $1.84M | $1.73M | $1.96M |
| Dividends paid | $9.66M | $9.63M | $9.60M | $9.57M | $9.54M |
| Share buybacks | $1.15M | $904,000 | $393,000 | $171,000 | $383,000 |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.